Value Through Innovation
Our Animal Health business made excellent progress, due to our core business segments of swine and small animals. In 2011, we concluded another successful year with net sales of EUR 976 million and a year-on-year growth of +6 percent. This division's share in our total sales increased to around 7 percent.
Boehringer Ingelheim Animal Health has a wide range of products covering
- Biologicals
- Pharmaceuticals
- Natural Care
Boehringer Ingelheim is a research-driven group of companies. We are dedicated to researching, developing, manufacturing and marketing pharmaceuticals that improve health and quality of life. The Boehringer Ingelheim Corporation currently has more than 44,000 employees and 145 affiliated companies spread around the globe.